Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Latency-associated DNA methylation patterns among HIV-1 infected individuals with distinct disease progression courses or antiretroviral virologic response.
Mantovani N, Defelicibus A, da Silva IT, Cicero MF, Santana LC, Arnold R, de Castro DF, Duro RLS, Nishiyama-Jr MY, Junqueira-de-Azevedo ILM, da Silva BCM, da Silva Duarte AJ, Casseb J, de Barros Tenore S, Hunter J, Diaz RS, Komninakis SCV. Mantovani N, et al. Sci Rep. 2021 Nov 26;11(1):22993. doi: 10.1038/s41598-021-02463-0. Sci Rep. 2021. PMID: 34837007 Free PMC article.
3D Bioprinted Neural-Like Tissue as a Platform to Study Neurotropism of Mouse-Adapted SARS-CoV-2.
de Melo BAG, Mundim MV, Lemes RMR, Cruz EM, Ribeiro TN, Santiago CF, da Fonsêca JHL, Benincasa JC, Stilhano RS, Mantovani N, Santana LC, Durães-Carvalho R, Diaz RS, Janini LMR, Maricato JT, Porcionatto MA. de Melo BAG, et al. Adv Biol (Weinh). 2022 Aug;6(8):e2200002. doi: 10.1002/adbi.202200002. Epub 2022 May 6. Adv Biol (Weinh). 2022. PMID: 35521969 Free PMC article.
Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial.
Blum VF, Cimerman S, Hunter JR, Tierno P, Lacerda A, Soeiro A, Cardoso F, Bellei NC, Maricato J, Mantovani N, Vassao M, Dias D, Galinskas J, Janini LMR, Santos-Oliveira JR, Da-Cruz AM, Diaz RS. Blum VF, et al. EClinicalMedicine. 2021 Jul;37:100981. doi: 10.1016/j.eclinm.2021.100981. Epub 2021 Jun 27. EClinicalMedicine. 2021. PMID: 34222847 Free PMC article.
Corrigendum to "Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial." [EClinicalMedicine 37 (2021) 100981].
Blum VF, Cimerman S, Hunter JR, Tierno P, Lacerda A, Soeiro A, Cardoso F, Bellei NC, Maricato J, Mantovani N, Vassao M, Dias D, Galinskas J, Janini LMR, Santos-Oliveira JR, Da-Cruz AM, Diaz RS. Blum VF, et al. EClinicalMedicine. 2021 Nov;41:101203. doi: 10.1016/j.eclinm.2021.101203. Epub 2021 Nov 14. EClinicalMedicine. 2021. PMID: 34805808 Free PMC article.